Health
Why Pfizer is bettting big on a Lyme disease vaccine that technically missed its goal
Is a 73% success rate good enough when the official target was higher? Pfizer and its partner Valneva think so. They're moving ahead with FDA and European regulatory filings for their Lyme disease
News Discover the latest in news.
View All
Why LaGuardia Airport Still Faces Massive Disruptions After the Air Canada Crash
Why US Runways are Getting Safer and Why It Took So Long
The Seconds Between the Silence and the Static
The New Face of Justice at the Southern District of New York
The Terminal Silence Behind the LaGuardia Disaster
Why the Supreme Court Just Saved Journalism by Rejecting Priscilla Villarreal
The Lewandowski Inquiry is a Masterclass in Political Performance Art
Washington’s Lobbying Charade and the Myth of the Secret Foreign Agent
Business Discover the latest in business.
View All/cloudfront-us-east-2.images.arcpublishing.com/reuters/U2NINRXSAFOJVLPJ73DUVKGDUQ.jpg)
Why Austan Goolsbee is Getting Nervous About Inflation Again
Danone Buying Huel is a Desperate Pivot to Ultra Processed Profits Not a Health Revolution
The High Cost of the Exit Sign
The $200 Billion Handshake
The Diesel Gamble and the Hidden War for American Freight
Why the BTS Comeback Crowd Numbers are Messing With Hybe Stock
Toyota $1 Billion U.S. Hedge and the End of the EV Fairy Tale
The Crude Reality of China Fuel Queues
Technology Discover the latest in technology.
View All
The Pentagon War on Claude
Systemic Failure in Ground Traffic Control The LaGuardia Runway Collision Mechanics
The Price of Silence in a Digital Clearing
Why Your Next Pint Might Be Made From Captured Carbon
Data Gluttony is Killing Climate Adaptation
The Architecture of Digital Siege Analysis of Irans Multilayered Connectivity Suppression
The Kinetic Failure Chain Analyzing Interceptor Fragmentation and Collateral Risk in Integrated Air Defense
The Myth of the Lone Controller and the Failure of Flight Deck Logic
Browse by Category
Explore topics you care about